Technology & Software Global On demand · 24-48h

Global Nutraceutical Contract Manufacturing Services Market Strategic Research Report

Name: Global Nutraceutical Contract Manufacturing Services Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global Nutraceutical Contract Manufacturing Services Market …

$3,500 USD

Strategic Research Report

Global Nutraceutical Contract Manufacturing Services Market

$8.46B2025

9%CAGR

2032Forecast

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Capsules and Tablets, Softgels and Gels, Powders, Liquids, Other

By Application: Large enterprises, SMEs

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: NBTY, Inc., Glanbia Nutritionals, Lonza Group, Capstone Nutrition, Pharmavite LLC, Catalent, Inc., Nutracap Labs, NutraScience Labs, ABH Pharma, Inc., Aenova Group, Sirio Pharma Co., Ltd., Supplement Manufacturing Partners, Vit-Best Nutrition, SMP Nutra, Nutra Solutions USA

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2025 · forecast to 2032

Length: 114 pages

Market size 2025

$8.46B

Billion USD

Forecast CAGR

2025-2032

Forecast 2032

$15.5B

Projected

Régions

Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Nutraceutical Contract Manufacturing Services market size is predicted to grow from US$ 8,462 million in 2025 to US$ 15,250 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.

Nutraceutical Contract Manufacturing Services are specialized services provided by third-party manufacturers who produce nutraceutical products (e.g., vitamins, dietary supplements, herbal products, and functional foods) on behalf of other brands or companies. These services are integral for companies that seek high-quality production without investing in manufacturing facilities, regulatory compliance, and production expertise.

Global key Nutraceutical Contract Manufacturing Services players cover NBTY, Inc., Glanbia Nutritionals, Lonza Group, Capstone Nutrition, Pharmavite LLC, etc.

This report presents a comprehensive overview of the global Nutraceutical Contract Manufacturing Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Capsules and Tablets
Softgels and Gels
Powders
Liquids
Other

Segment by Application

Large enterprises
SMEs

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Nutraceutical Contract Manufacturing Services market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Large enterprises, SMEs evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Nutraceutical Contract Manufacturing Services Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports

Market size CAGR 9%

Regional growth momentum

Market share by segment

Key metrics

Base value

$8.46B

2025

Forecast

$15.5B

2032

CAGR

2025–2032

Régions

global

Key companies

NBTY, Inc.Glanbia NutritionalsLonza GroupCapstone NutritionPharmavite LLCCatalent, Inc.Nutracap LabsNutraScience Labs

Segments covered in this report

By Type

Capsules and TabletsSoftgels and GelsPowdersLiquidsOther

By Application

Large enterprisesSMEs

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Capsules and Tablets
3.1.3 Softgels and Gels
3.1.4 Powders
3.1.5 Liquids
3.1.6 Other
3.1.7 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Large enterprises
4.1.3 SMEs
4.1.4 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 NBTY, Inc.
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Glanbia Nutritionals
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 Lonza Group
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 Capstone Nutrition
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 Pharmavite LLC
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 Catalent, Inc.
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 Nutracap Labs
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 NutraScience Labs
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 ABH Pharma, Inc.
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Aenova Group
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Sirio Pharma Co., Ltd.
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Supplement Manufacturing Partners
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 Vit-Best Nutrition
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 SMP Nutra
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 Nutra Solutions USA
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Nutraceutical Contract Manufacturing Services market?

The global Nutraceutical Contract Manufacturing Services market is estimated at US$ 8.46 billion in 2025 (base year) and is projected to reach US$ 15.25 billion by 2032.

What is the forecast CAGR for the Nutraceutical Contract Manufacturing Services market?

The market is expected to grow at a CAGR of 9.0% from 2026 to 2032, expanding from US$ 8.46 billion in 2025 to US$ 15.25 billion in 2032, roughly 1.8 times its base-year value.

What is Nutraceutical Contract Manufacturing Services?

What are the main segments of the Nutraceutical Contract Manufacturing Services market by type?

By type, the market is segmented into Capsules and Tablets, Softgels and Gels, Powders, Liquids and Other.

Which applications drive demand in the Nutraceutical Contract Manufacturing Services market?

Key applications covered include Large enterprises and SMEs.

Who are the key players in the Nutraceutical Contract Manufacturing Services market?

Key players profiled include NBTY, Glanbia Nutritionals, Lonza Group, Capstone Nutrition, Pharmavite LLC, Catalent, Nutracap Labs and NutraScience Labs, among 15 companies covered in total.

Which regions and countries are covered for Nutraceutical Contract Manufacturing Services?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

Who should buy the Nutraceutical Contract Manufacturing Services market report?

The report is intended for manufacturers and solution providers, distributors and end users in Large enterprises and SMEs, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Nutraceutical Contract Manufacturing Services market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.